期刊文献+

自拟益气养肾消解方结合西药治疗早期糖尿病肾病疗效观察

The Effect of Yiqi Yangshen Digestion Solution Combined With Western Medicine in Treatment of Early Diabetic Nephropathy
在线阅读 下载PDF
导出
摘要 目的评价自拟益气养肾消解方联合缬沙坦治疗糖尿病肾病(DN)的临床效果。方法选择我院收治的EDN患者随机分为两组,对照组采用缬沙坦进行治疗,观察组联合应用自拟益气养肾消解方进行治疗,比较两组临床疗效、临床指标。结果观察组临床有效率优于对照组,差异有统计学意义(P<0.05);治疗后观察组临床指标改善优于对照组,差异有统计学意义(P<0.05)。结论自拟益气养肾消解方联合缬沙坦可以有效改善血糖指标,调节肾脏功能,取得比较满意的临床疗效。 Objective To evaluate the Yiqi Yangshen Digestion Solution and valsartan treatment of diabetic nephropathy (DN) clinical results. Methods EDN our hospital were randomly divided into two groups, the use of valsartan treatment, combined with the observation group since Yiqi Yang Shen Fang digestion treatment, comparative clinical efficacy, clinical indicators. Results The clinical effective of observation group was better than the control group, the difference was statistically significant (P〈0.05), clinical improvement indicators observed after treatment group than the control group, the difference was statistically significant (P〈0.05). Conclusion Yiqi Yangshen Digestion Solution and valsartan can effectively improve blood sugar, regulate renal function, achieve more satisfactory clinical outcome.
作者 李进
出处 《中国继续医学教育》 2015年第21期208-209,共2页 China Continuing Medical Education
关键词 自拟益气养肾消解方 缬沙坦 糖尿病肾病 中西医 Yiqi Yangshen Digestion Solution Valsartan Diabetic nephropathy Chinese and western medicine
  • 相关文献

参考文献3

二级参考文献13

  • 1胡茂清,张执玉.糖尿病肾病的合理治疗[J].四川省卫生管理干部学院学报,2005,24(4):286-289. 被引量:6
  • 2Makino H,Nakamura Y,Wada J.Remission and regression of diabetic nephropathy.Hypertens Res,2003,26(7):515-519.
  • 3Gilbert RE,Cox A,Wu LL,et al.Expression of transfor ming groth-factor-t31 and type Ⅳ collagen in the tubulointerstitrum in experimental diabetes effects of ACE inhibition.Diabets,1998,47(3):414-422.
  • 4Ulicna O,Cizova M,Kolesar P,et al.Bioenergetics of livermi-tochondria after administration of ramipril in experimental dia-bets mellitus.Bratisl Lek Listy,1997,98(12):687-691.
  • 5Lewis EJ,Hunsicker LG,Clarkew R,et al.Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropatay due to type 2 diabeters.N Engl J Med,2001,345(12):851-855.
  • 6廖二元;莫朝辉.内分泌学[M]北京:人民卫生出版社,20071448.
  • 7Mogensen CE,Schmitz A,Christensen CR. Comparative renal pathophysiololgy,relevant to IDDM and NIDDM patients[J].Diabetes Metabolisn Rev,1998,(5):453.doi:10.1016/j.jmb.2009.06.078.
  • 8郑筱萸.中药新药临床研究指导原则[M]北京:中国医药科技出版社,2002232-237.
  • 9万红梅,孙侃,常向云,韩刚.醛固酮拮抗剂与糖尿病肾病的研究进展[J].现代生物医学进展,2010,10(13):2571-2573. 被引量:5
  • 10李黎,李勤,李世云.醛固酮受体拮抗剂抗氧化及对糖尿病肾病保护作用[J].四川医学,2011,32(2):274-277. 被引量:5

共引文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部